New YorkEstablishes a medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants test strip program
What it does
Directs the commissioner of the office of alcoholism and substance abuse services to establish a program for individuals to receive free drug test strips to detect the presence of medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants; directs the commissioner of the office of alcoholism and substance abuse services, in cooperation with the commissioner of the department of health, to develop and conduct a public awareness and educational campaign on the dangers of medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed 1st Chamber
- Passed 2nd Chamber
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Jun 4RETURNED TO ASSEMBLYLatest
- Vote recorded Floor Vote. Result: pass.Upper
- Jun 4PASSED SENATEPassed 2nd Chamber
- Jun 43RD READING CAL.1742
- Jun 4SUBSTITUTED FOR S9221
- Apr 27REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERSMinor
- Vote recorded Assembly Vote. Result: pass.Lower
- Apr 27DELIVERED TO SENATE
- Apr 27PASSED ASSEMBLYPassed 1st Chamber
- Apr 23ADVANCED TO THIRD READING CAL.366
- Apr 21REPORTED
- Feb 10REPORTED REFERRED TO WAYS AND MEANSMinor
- Jan 7REFERRED TO ALCOHOLISM AND DRUG ABUSEMinor
- Jun 4RETURNED TO ASSEMBLYLatest
- 2025
- Aug 13REFERRED TO ALCOHOLISM AND DRUG ABUSEIntroduced